(Q39418566)

English

Effects of cold ischemia and inflammatory tumor microenvironment on detection of PI3K/AKT and MAPK pathway activation patterns in clinical cancer samples

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Effects of cold ischemia and inflammatory tumor microenvironment on detection of PI3K/AKT and MAPK pathway activation patterns in clinical cancer samples (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

0 references

author name string

Christel Bonnas

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Katja Specht

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Olivia Spleiss

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Stefanie Froehner

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Gabriele Dietmann

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Juliane M Krüger

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Susanne Arbogast

7

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Friedrich Feuerhake

8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

language of work or name

0 references

publication date

28 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

131

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1621-1632

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

Signal integration by JNK and p38 MAPK pathways in cancer development

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

Mutations of the BRAF gene in human cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

PI3K pathway alterations in cancer: variations on a theme

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

PI3K/Akt signalling pathway and cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

MAP kinase signalling pathways in cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

Inferring tumor progression from genomic heterogeneity

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

Immunohistochemical assessment of protein phosphorylation state: the dream and the reality

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

Phosphorylation state-specific antibodies: applications in investigative and diagnostic pathology

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

AKT activation predicts outcome in breast cancer patients treated with tamoxifen

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

Immunohistochemical expression of PTEN and phosphorylated Akt are not correlated with clinical outcome in breast cancer patients treated with trastuzumab-containing neo-adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

Preanalytical aspects: a neglected issue

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

A portrait of tissue phosphoprotein stability in the clinical tissue procurement process

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

Stability of phosphoprotein as a biological marker of tumor signaling

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

Activation of NF-kappaB and MAP kinase cascades by hypothermic stress in endothelial cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

BRAF mutation predicts sensitivity to MEK inhibition

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

Genetic predictors of MEK dependence in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

PI3K pathway activation mediates resistance to MEK inhibitors in KRAS mutant cancers

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

(V600E)BRAF is associated with disabled feedback inhibition of RAF-MEK signaling and elevated transcriptional output of the pathway

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27422

21 January 2018

Identifiers

10.1002/IJC.27422

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

release_z5g2tde7cvg27pzkpxlqdj4zvu

1 reference

https://api.fatcat.wiki/v0/release/z5g2tde7cvg27pzkpxlqdj4zvu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39418566&oldid=1840327729"